A Randomized SAD and MAD Study Evaluating the Safety and Tolerability of RPh201 in Healthy Subjects and in Adults With Alzheimer's Disease

This study is currently recruiting participants. (see Contacts and Locations)
Verified December 2014 by Regenera Pharma Ltd
Sponsor:
Collaborator:
INC Research
Information provided by (Responsible Party):
Regenera Pharma Ltd
ClinicalTrials.gov Identifier:
NCT01513967
First received: January 17, 2012
Last updated: December 23, 2014
Last verified: December 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2016
  Estimated Primary Completion Date: June 2015 (Final data collection date for primary outcome measure)